Shenzhu pharmaceutical composition for treating atrophic gastritis and application thereof

A technology of Shenshu Pingwei and composition, which is applied in the field of Shenshu Pingwei pharmaceutical composition, which can solve the problems of side effects, high price, inability to completely improve symptoms and prognosis, and achieve the effect of improving clinical symptoms

Inactive Publication Date: 2016-03-30
TIANCHANG HOSPITAL OF TRADITIONAL CHINESE MEDICINE
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, Western medicine has no specific medicines, and can only treat symptoms, such as suppressing acid, promoting gastric motility, or neutralizing gastric acid, etc. The curative effect generally cannot completely improve symptoms and prognosis, and long-term use has certain side effects, and the price is relatively expensive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Shenzhu pharmaceutical composition for treating atrophic gastritis and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] A medicinal composition of Shenzhu and wilt, the raw materials of which include by weight: 10 parts of Codonopsis pilosula, 12 parts of Atractylodes macrocephala, 8 parts of skullcap, 17 parts of purple salvia miltiorrhiza, 25 parts of coix seed, 12 parts of Agrimony, 12 parts of Hedyotis, Banzhilian 17 parts, Dandelion 13 parts, winter melon seeds 12 parts, Curcuma 8 parts, Citrus aurantii 11 parts.

Embodiment 2

[0029] A medicinal composition of Shenzhu and wilt, the raw materials of which include by weight: 20 parts of Codonopsis pilosula, 8 parts of Atractylodes macrocephala, 12 parts of Scutellaria baicalensis, 13 parts of purple salvia miltiorrhiza, 35 parts of coix seed, 8 parts of Agrimony, 18 parts of Hedyotis, 13 parts of Scutellaria barbata, 17 parts of dandelion, 8 parts of winter melon seeds, 12 parts of curcuma, and 9 parts of Citrus aurantii.

Embodiment 3

[0031] A pharmaceutical composition for treating wilting ginseng, the raw materials of which include by weight: 13 parts of Codonopsis pilosula, 11 parts of Atractylodes macrocephala, 9 parts of Scutellaria baicalensis, 16 parts of purple salvia miltiorrhiza, 28 parts of coix seed, 11 parts of Agrimony, 13 parts of Hedyotis, 16 parts of Scutellaria barbata, 14 parts of dandelion, 11 parts of winter melon seeds, 9 parts of curcuma, and 10.5 parts of Citrus aurantii.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a Shenzhu pharmaceutical composition for treating atrophic gastritis. The pharmaceutical composition comprises the following raw materials in parts by weight: 10-20 parts of codonopsis pilosula, 8-12 parts of largehead atractylodes rhizome, 8-12 parts of baical skullcap root, 13-17 parts of danshen root, 25-35 parts of coix seed, 8-12 parts of hairyvein agrimonia herb and bud, 12-18 parts of spreading hedyotis herb, 13-17 parts of barbed skullcap herb, 13-17 parts of Mongolian dandelion herb, 8-12 parts of Chinese waxgourd semen, 8-12 parts of curcuma zedoary and 9-11 parts of bitter orange. The invention also discloses an application of the Shenzhu pharmaceutical composition for treating atrophic gastritis in preparation of medicines for treating atrophic gastritis, intestinal metaplasia and atypical hyperplasia. The Shenzhu pharmaceutical composition disclosed by the invention has the effects of replenishing qi to invigorate the spleen, removing heat and dampness, and detoxifying and activating blood circulation, can reverse and prevent gastric mucosa carcinogenesis, and can be used for treating atrophic gastritis, intestinal metaplasia and atypical hyperplasia which are caused by weakness of spleen and stomach and damp-heat syndromes.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a medicinal composition of Shenshu and atrophy and its application. Background technique [0002] Chronic atrophic gastritis belongs to the category of "epigastric pain", "noisy", "abdominal distension" and "stomach fullness" in traditional Chinese medicine. The ups and downs of the body are unbalanced, dampness is generated from the inside, accumulates for a long time to transform heat, dampness and heat intertwine, stay in the stomach and further hinder the function of the spleen and stomach, resulting in stomach pain, noise, abdominal distension, fullness and discomfort, etc., pathological examination can be manifested as gastric Glandular atrophy, intestinal metaplasia, dysplasia. This disease claims precancerous lesion again, and its incidence rate is high, endangers human health. [0003] At present, Western medicine has no specific medicines and can...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P1/04A61P1/00
CPCA61K36/344A61K36/11A61K36/19A61K36/28A61K36/284A61K36/288A61K36/34A61K36/42A61K36/537A61K36/539A61K36/73A61K36/748A61K36/752A61K36/80A61K36/8994A61K36/9066A61K2300/00
Inventor 何镔
Owner TIANCHANG HOSPITAL OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products